Forbairt agus cur i bhfeidhm fáinní stoptha ocsaídiúcháin roghnacha le grúpaí iomadúla sulfhidril

Forbairt agus cur i bhfeidhm fáinní stoptha ocsaídiúcháin roghnacha le grúpaí iomadúla sulfhidril

Research background and challenges

Selective ring closure of multiple sulfhydryl compounds is a key step in the synthesis of sulfur-containing heterocyclic compounds, but the traditional method has the following problems:

  • Multiple sulfhydryl reaction activities are similar, making it difficult to achieve selective control. Many side reactions, complex products, and difficult to isolate and purify. The reaction conditions are harsh and the scope of application is limited. We have successfully developed a new selective oxidative ring-closing technology, which completely solves the above problems and achieves efficient and precise ring-closing reaction.

Technical breakthroughs

  • Innovative oxidation system: The first alkyne amide-based oxidation system is proposed, which significantly improves the selectivity.
  • Unique reaction design: through a variety of different positions of the sulfhydryl substrate, the precise ring closure of multiple sulfhydryl substrates is achieved.

Technical Advantages

  • High selectivity: precise identification of target sites among multiple sulfhydryl substrates to achieve single product generation.
  • High efficiency: the reaction conditions are mild, and the reaction yield is significantly improved.
  • Universality: applicable to the synthesis of various sulfur-containing heterocyclic compounds.

Application Fields

  • Drug synthesis: construction of sulfur-containing heterocyclic drug molecules (e.g., thiophene, benzothiophene, dithiopyrrolidine, srl.).
  • Functional materials: preparation of sulfur-containing polymer materials (e.g. self-repairing materials, conductive polymers, srl.).
  • Chemical biology: study the formation and function of protein disulfide bonds.

Avatar admin

Xiaoxia Chen

Drugaí Nua R&D Teicneoir Saineolas Croí: Fionnachtain sprice, caidreamh struchtúr-gníomhaíochta (SAR) anailís, comhchuingeacha peptide-drugaí (PDCanna), agus forbairt peptídí frith-aosaithe agus meitibileach.

Próifíl: Tá Xiaoxia Chen i gceannas ar an bhfionnachtain luath agus ar an taighde réamhchliniciúil le haghaidh roinnt drugaí peptide meitibileach agus meall-dírithe.. Ní hamháin go bhfuil sí inniúil ar scagadh ard-tréchur na leabharlann peptide ach tá sí oilte freisin ar bhitheolaíocht ríomhaireachtúil le cúnamh AI a úsáid le haghaidh seicheamh peptíde de novo a dhearadh.. Faoi láthair, tá sí i gceannas ar fhoireann atá tiomanta do thaighde agus forbairt dhomhain ar ghníomhairí ilfheidhmeacha den chéad ghlúin eile (mar shampla dual- nó trí-sprioc peptides saill-laghdaithe) agus peptides deisiúcháin fíocháin thar a bheith gníomhach.

Seiceáilte Fíricí & Treoirlínte Eagarthóireachta
Athbhreithnithe ag: Saineolaithe Ábhar
Roinn an t-alt seo
Baile Cuardach Whatsapp Seirbhísí Táirge